SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

02 May 2025 Evaluate
A fair growth of 14.60% in the revenue at Rs. 1076.48 millions was reported in the March 2025 quarter as compared to Rs. 939.31 millions during year-ago period.A big loss of -86.72% reported for the quarter ended March 2025 to Rs. 10.95  millions from Rs. 82.47 millions.The company reported a degrowth in operating Profit to 91.98 millions from 187.25 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1076.48 939.31 14.60 3664.15 3786.77 -3.24 3664.15 3786.77 -3.24
Other Income 12.95 45.27 -71.39 35.61 75.08 -52.57 35.61 75.08 -52.57
PBIDT 91.98 187.25 -50.88 294.05 743.73 -60.46 294.05 743.73 -60.46
Interest 3.88 2.18 77.98 12.90 65.07 -80.18 12.90 65.07 -80.18
PBDT 88.10 185.07 -52.40 281.15 678.66 -58.57 281.15 678.66 -58.57
Depreciation 72.56 62.31 16.45 276.54 256.01 8.02 276.54 256.01 8.02
PBT 15.54 122.76 -87.34 4.61 422.65 -98.91 4.61 422.65 -98.91
TAX 4.59 40.29 -88.61 1.34 129.17 -98.96 1.34 129.17 -98.96
Deferred Tax 4.73 19.02 -75.13 1.32 55.73 -97.63 1.32 55.73 -97.63
PAT 10.95 82.47 -86.72 3.27 293.48 -98.89 3.27 293.48 -98.89
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 233.92 0.00
PBIDTM(%) 8.54 19.93 -57.14 8.03 19.64 -59.14 8.03 19.64 -59.14

Tatva Chintan Pharma Share Price

1275.10 -8.55 (-0.67%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×